Castle Biosciences (CSTL) Insider Trading & Ownership $29.81 +0.93 (+3.22%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Castle Biosciences (NASDAQ:CSTL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.32 M Get CSTL Insider Trade Alerts Want to know when executives and insiders are buying or selling Castle Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CSTL Insider Buying and Selling by Quarter Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Castle Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/15/2024Frank StokesCFOSell6,923$29.93$207,205.39 11/12/2024Derek J MaetzoldInsiderSell1,972$34.15$67,343.80 11/5/2024Tobin W JuvenalInsiderSell3,507$35.56$124,708.92 10/14/2024Derek J MaetzoldInsiderSell1,972$32.27$63,636.44 10/8/2024Derek J MaetzoldInsiderSell986$30.27$29,846.22 10/7/2024Daniel BradburyDirectorSell7,867$29.44$231,604.48 Automatic Income (from home) (Ad)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video10/4/2024Derek J MaetzoldInsiderSell986$28.73$28,327.78 8/12/2024Daniel BradburyDirectorSell7,883$26.65$210,081.95 8/7/2024Frank StokesCFOSell10,000$25.70$257,000.00 8/1/2024Kristen M OelschlagerCOOSell12,989$23.06$299,526.34 7/29/2024Kristen M OelschlagerCOOSell2,793$22.06$61,613.58 6/3/2024Derek J MaetzoldInsiderSell2,368$23.40$55,411.20 5/6/2024Daniel BradburyDirectorSell23,323$24.64$574,678.72 5/6/2024Derek J MaetzoldInsiderSell2,368$24.72$58,536.96 4/23/2024Derek J MaetzoldInsiderSell421$20.11$8,466.31 4/12/2024Derek J MaetzoldInsiderSell1,947$20.35$39,621.45 4/8/2024Daniel BradburyDirectorSell2,400$20.45$49,080.00 4/4/2024Daniel BradburyDirectorSell9,152$21.45$196,310.40 4/3/2024Derek J MaetzoldInsiderSell2,368$21.70$51,385.60 3/20/2024Derek J MaetzoldInsiderSell2,295$20.27$46,519.65 3/7/2024Derek J MaetzoldInsiderSell2,372$20.77$49,266.44 3/5/2024Derek J MaetzoldInsiderSell4,131$21.41$88,444.71 3/4/2024Daniel BradburyDirectorSell23,323$20.68$482,319.64 2/7/2024Daniel BradburyDirectorSell2,074$23.20$48,116.80 1/4/2024Daniel BradburyDirectorSell18,223$20.40$371,749.20 12/28/2023Derek J MaetzoldInsiderSell3,954$22.17$87,660.18 12/26/2023Derek J MaetzoldInsiderSell5,180$21.93$113,597.40 12/22/2023Derek J MaetzoldInsiderSell5,224$21.96$114,719.04 12/20/2023Derek J MaetzoldInsiderSell5,201$21.05$109,481.05 12/18/2023Derek J MaetzoldInsiderSell5,720$20.27$115,944.40 12/12/2023Daniel BradburyDirectorSell1,200$20.01$24,012.00 12/12/2023Derek J MaetzoldInsiderSell546$20.01$10,925.46 12/8/2023Daniel BradburyDirectorSell6,875$20.09$138,118.75 12/8/2023Derek J MaetzoldInsiderSell2,322$20.10$46,672.20 12/6/2023Daniel BradburyDirectorSell200$20.02$4,004.00 12/6/2023Derek J MaetzoldInsiderSell48$20.02$960.96 12/4/2023Daniel BradburyDirectorSell4,340$20.08$87,147.20 12/4/2023Derek J MaetzoldInsiderSell1,379$20.08$27,690.32 12/1/2023Daniel BradburyDirectorSell9,545$20.05$191,377.25 12/1/2023Derek J MaetzoldInsiderSell3,235$20.06$64,894.10 Automatic Income (from home) (Ad)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video11/29/2023Daniel BradburyDirectorSell17,342$20.12$348,921.04 11/29/2023Derek J MaetzoldInsiderSell5,743$20.13$115,606.59 11/24/2023Daniel BradburyDirectorSell800$20.02$16,016.00 11/24/2023Derek J MaetzoldInsiderSell287$20.03$5,748.61 (Data available from 1/1/2013 forward) CSTL Insider Trading Activity - Frequently Asked Questions Who is on Castle Biosciences's Insider Roster? The list of insiders at Castle Biosciences includes Daniel Bradbury, Derek J Maetzold, Ellen Goldberg, Frank Stokes, Kristen M Oelschlager, Tiffany Olson, and Tobin W Juvenal. Learn more on insiders at CSTL. What percentage of Castle Biosciences stock is owned by insiders? 7.20% of Castle Biosciences stock is owned by insiders. Learn more on CSTL's insider holdings. Which Castle Biosciences insiders have been buying company stock? The following insiders have purchased CSTL shares in the last 24 months: Ellen Goldberg ($69,024.00), and Tiffany Olson ($24,983.00). How much insider buying is happening at Castle Biosciences? Insiders have purchased a total of 5,962 CSTL shares in the last 24 months for a total of $94,007.00 bought. Which Castle Biosciences insiders have been selling company stock? The following insiders have sold CSTL shares in the last 24 months: Daniel Bradbury ($5,446,373.60), Derek J Maetzold ($2,132,763.19), Frank Stokes ($464,205.39), Kristen M Oelschlager ($361,139.92), and Tobin W Juvenal ($124,708.92). How much insider selling is happening at Castle Biosciences? Insiders have sold a total of 383,052 Castle Biosciences shares in the last 24 months for a total of $8,529,191.02 sold. Castle Biosciences Key ExecutivesMr. Derek J. Maetzold (Age 62)Founder, CEO, President & Director Compensation: $1.45M5 recent tradesMr. Frank Stokes (Age 53)CFO & Treasurer Compensation: $849.36k2 recent tradesMs. Kristen M. Oelschlager R.N. (Age 56)Chief Operating Officer Compensation: $782.7k2 recent tradesMr. Tobin W. Juvenal (Age 64)Chief Commercial Officer Compensation: $782.7k1 recent tradesCamilla ZuckeroVice President of Investor Relations & Corporate AffairsMs. Alice Bahner IzzoSenior Vice President of MarketingMr. Kevin DomanVice President of SalesMs. Keli GreenbergVP of Human Resources & Executive Director of Human ResourcesDr. Robert W. Cook Ph.D. (Age 52)Senior Vice President of Research & Development Dr. Matthew Goldberg M.D.Senior Vice President of Medical More Insider Trading Tools from MarketBeat Related Companies MYGN Insider Transactions VCYT Insider Transactions SGRY Insider Transactions LFST Insider Transactions PACS Insider Transactions PRVA Insider Transactions ADUS Insider Transactions WGS Insider Transactions NHC Insider Transactions TDOC Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CSTL) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.